The discovery of antibodies that bind with high affinity to clinically relevant antigens can be sped up by leveraging next-generation sequencing to screen hundreds of millions of antibody–antigen interactions.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$99.00 per year
only $8.25 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jumper, J. et al. Nature 596, 583–589 (2021).
Dauparas, J. et al. Science 378, 49–56 (2022).
Antanasijevic, A. et al. Sci. Adv. 8, eabk2039 (2022).
Tsuboyama, K. et al. Nature 620, 434–444 (2023).
Porebski, B. T. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-023-01093-3 (2023).
Mason, D. M. et al. Nat. Biomed. Eng. 5, 600–612 (2021).
Kowalsky, C. A. & Whitehead, T. A. Proteins 84, 1914–1928 (2016).
Smith, M. D., Case, M. A., Makowski, E. K. & Tessier, P. M. Bioinformatics 39, btad446 (2023).
Hanes, J. & Plückthun, A. Proc. Natl Acad. Sci. USA 94, 4937–4942 (1997).
Kovaltsuk, A. et al. J. Immunol. 201, 2502–2509 (2018).
Hsu, C., Nisonoff, H., Fannjiang, C. & Listgarten, J. Nat. Biotechnol. 40, 1114–1122 (2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Whitehead, T.A. Deep screening of antibody–antigen affinities. Nat. Biomed. Eng 8, 203–204 (2024). https://doi.org/10.1038/s41551-023-01169-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41551-023-01169-0